Kabushiki Kaisha obtains United States patent.(Brief Article)

Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (Okayama, Japan) has patented a receptor protein which recognizes a novel cytokine, i.e., interleukin-18, a monoclonal antibody specific to the protein, and uses thereof. The receptor protein is useful as pharmaceutical to treat …